Financial statements Ucb Pharma
Cash flow statement of Ucb Pharma
Company age:
Age:
23 y. 4 m. 28 d.
Share capital:
Share capital:
740 800 PLN
Cash inflows of UCB PHARMA
|
Year
|
2022
|
2023
|
|---|---|---|
| Net cash from operating expenses | -8 646,00 | 2 137,00 |
| Net cash flow from investing activities | 3 079,00 | 1 188,00 |
| Net cash flow from financial activities | -9 100,00 | -6 885,00 |
| Total net cash flow | -14 667,00 | -3 560,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.